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Recent studies have focused on characterizing the 
cytokine profile produced in the epidermis during the 
sensitization phase of contact sensitivity (CS). Some 
prior studies h ave also identified altered individual 
cytokine mRNA profiles in skin or draining lymph 
nodes (or several cytokine luRNA profiles in the 
epidermis) during the elicitation phase of es. In this 
study we determined the dynamics of appearance of a 
battery of cytokine mRNA levels in both the epider-
mis and dermis during the elicitation phase of CS. 
We isolated mRNA from dispase-separated epider-
mis and dermis ofTNCB-sensitized and naive BALB/c 
mice at various times after TNCB challenge. Changes 
in IFN-y and IL-4 mRNA levels (by semiquantita-
tive RT-PCR) were more reproducible and dramatic 
than those of other cytoldnes studied (IL-l/3, IL-2, 
IL-l0, and IL-12 p40). Compared to naive mice, 
sensitized mice had significantly elevated IL-4 mRNA 
signals 9 and 24 h (dermis), and 24 h (epidermis), after 
T here is good e vidence that T -helpc l' 1 (Thl) cells afe c ritica ll y in volved in. de .. layed type h ypersensitivicy . (DTH) rcactio ns. C her and Mosmann (198 7) dem-onstrated that onJy T hl ce ll cloncs could passive ly transfc r DTH, and Hauser (1990) sho w ed th~t Thl 
cells m edia te contact sensitIvIty (CS ), a fo rm of DT H . Further-
more , IFN-y, a T hl-type cytokine, is an important mediator o f 
D T H (I ssckutz ct "I, 1988; Martin ct "I, 1988; Fo n g and Mosmann , 
1989) . Based on thesc studies, the CS reac tion is gen eralJ y regarded 
as a Th I-m ediated p rocess. 
R.ecently, invesr.igators have studied cyto kinc gene ex prcssion 
patterns in th e cpidermis (Enk and Katz, 1992) and in dralnin g 
lymph n odes (M ohl e r and Butle r, 1990; T hom son ct "I, .19(3) 
durin g th e sensitiza tio n phase of CS. AltllOlIgh selectcd studies hav e 
focused o n the contributioll o f illdi vidual cytokin cs le.g., t umo r 
necrosis fa ctor- (.\' (Pi gue t ('( "I, 19(1) , inte rle ukin (I L)- I (Larscn cf 
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TNCB challenge. The increased IL-4 mRNA levels 
were mast-ceil-independent, because sensitized 
mast-cell-deficient mice showed similar increases in 
IL-4 mRNA. To examine the role of endogenous IL-4 
in CS elicitation, sensitized mice were treated with 
anti-IL-4 mAb 1 h before challenge. In accord with 
prior studies, anti-IL-4 mAb-pretreated mice showed 
increased ear swelling 24 h after challenge compared 
to mice pretreated with isotype control mAb. Anti-
IL-4 InAb pretreatment also enhanced IFN-y, IL-2, 
IL-12 p40, and IL-l/3 (but not IL-l0) mRNA signals 
in the dermis of sensitized and challenged mice. 
These data indicate that IL-4 is produced in murine 
skin during the elicitation phase of CS and is an 
important down-modulator of inflammation. IL-4 
may blunt CS by regulating local production of 
proinflammatory cytokines. Key lVords: T-l,elpe,' cells 
Tid alld Th2/mRNA. ] Invest Del'matof 108:406-411J 
1997 
"I, 1988), IL- 4 (G;ll1ram er "I , 1992; Be rg ei ai, 1995; Salerno et ai, 
1995), and lL-l 0 (Ferguson ct "I , 1994; Kondo el nl, 1994a; Schwarz 
el (1/ , 1994; Berg e/ tI/, 1995)] to th e eli cit,ltion phase ofCS, only one 
prior study has addressed the epidermall y delived cytokine n etwork 
pardcipating in this inflammatory reac tion (Kondo eI "I, 1994b). In 
th e lattcr study, ncither dermaJly derived cytokines nor ep idennally 
de rived intc rfel'on-y (IFN-y) , 1L-2. 1L-4, and IL-12 mRNAs w ere 
studied. Therefore , in the current study we examin ed the dynami cs 
of th c appcarance of these and a battery of other cytokin e mRNAs 
in both the cp idermis and dermis during the e li ciGltion phase orcs. 
We quantitated [L-1 (3, IL-2, IL-4, lL-10, lL-1 2 p40, and IFN-y 
1111~ A le vels in murine epidermis and dermis during the elicitation 
phase of CS. Each cytok ine mRNA ex hibited distin c t reproducible 
changes after challengc. Intc restingly, IL-4 was clearly lIpreglllated 
latc in the e lic itation phase but not during the sensitization phase. 
I L-4 is a w ell - chara cte ri zed cyrokin e product ofT-he lpe r 2 (Th 2) 
cells (M osmanll cl "I, 1986) . It has B-ce ll-stimula ting 'lctivity . 
including reg ulation of immunoglobulin isotype switching (Cotf-
l1Ian ('I (//. 1988; Paul , 1991), and can suppress Till-mediated 
immune responses (Pe leman ct "I. 191:i9; Martinez c( ti l, 1990). 
BecaLlse of its known biologi c ac tivities and because of OLlI' 
polymerase c1uJi n re;lc tion (pe R) data showing enhan ced lL--I 
mRNA sigrw ls in the elicitatio n ph:lse, we also determined w hether 
endogellous IL-4 might dampen CS elicitatio n rea ctions. Indeed , in 
kecping with the findings of Gaucam ('/ (If ( 199 2), \V e found that 
when n eutralizing anti- IL-4 monoclona l antibod y (mAb) was ad-
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Table I. PCR Primers, Product Sizes, and PCR Cycle Numbers 
Gene Prilncr Sequence Size(hp) Cycle 
G3PDH 5' 5'-TCATGACCACAGTCCATGCCATCAC 438 22 
3' 5'-GCCGTATTCATTGTCATACCAGGAAATG 
IL-I f3 5' 5'-ATGGCAACTGTTCCTGAACTCAACT 563 30 
3' 5 '-CAGGACAGGTATAGATTCTTTCCTTT 
IL-2 5' 5'-TTCAAGCTCCACTTCAAGCTCTACAGCGGAAG ·11 3 28 
3 ' 5'-GACAGAAGGCTATCCATCTCCTCAGAAAGTCC 
IL-4 5' 5'-CCAGCTAGTTGTCATCCTGCTCTTCTTTCTCG 357 29 
3' 5'-CAGTGATGTGGACTTGGACTCATTCATGGTGC 
IL-l 0 5' 5'-ATGCAGGACTTTAAGGGTTACTTGGGTT 455 26 
3' 5'-ATTTCGGAGAGAGGTACAAACGAGGTTT 
1[,-1 2 p40 5' 5 ' -CAGAAGCTAACCATCTCCTGGTTTG 3% 28 
3' 5 ' -TCCGGAGTAATTTGGTGCTTCACAC 
IFN-y 5' 5'-TGCATCTTGGCTTTGCAGCTCTTCCTCATGGC 365 30 
3' 5 '-TGGACCTGTGGGTTGTTGACCTCAAACTTGGC 
ministere d to mice b e fore e li c itation of CS . th e rc w e re en han ced 
ear swellin g (CS) respollse s , suggesting that c ndogenoLlS I L-4 is ;til 
im portant downrcgulato r of CS responscs. 
M ATERIALS AN D M ETH O DS 
Animals UAUI /c Illi ce wc re o btained fi'o lll the s.naU '1I1i .llal fi.cility oi" 
the National Cancer Institute (Frederick. MD). WBJ36F. IV/ IV'" '1I1d 
WB J3 6F . + / + ,"ice were purchased fi'olll the J acksou Laborato ry (Ba r 
Harbor, ME). A ll mice were used at 8-12 wk of age. 
Reagents Tri nitrochlorobe ll zcne (TN CB) was purclIHsed fi 'o lll Poly-
sciences (Warrington. PA) and croton oi l was purchased li'om Sig," " (S t. 
Lou is. MO) . Purifi ed rat allti- I L-4 neutra li zing m Al> t t J3 t t was provided by 
Dr. C raig W . Reyno lds (Natiolla l Cance r Institute, Frederick. M D) . 
Iso rype-l11atched colltrol m Ab was purclwsed fi 'o lll The Billding Site 
(B irminghan •. U.K.). 
Induction and Assay of Contact Sensitivity and Irritant Responses 
BA LB/c mice Were painted o n shaved abdo minal sk.in with t OO II I ofYX, or 
1 % TNCJ3 di sso lved in a 4: t mi xture o i" acetoue/o li ve o il. Six da)'s alter 
se nsitization , dorsal and ventra l sides of thc ca rs of nlicc were pail1ted w ith 
10 J.LI of I IXI or 0.5 1yo TN C lJ in a 1:9 mixture of ace to ne/o li ve o il o r with 
vehjcle alollc. and swelling respo n ses were l1H!aSllred ill the righ t car of each 
an imal ;. t 24 and 48 h . N o rl11a l l11i ce chall enged with TNCB se rved as 
nega tive CO il tro is to Illeasurc the n Ollspecifi c swe ll ill g caused h y c hc llI ical 
toxicity of TN C ll. 
Irritant respo nses were induced b y p;:}inting with 10 J.LI of I uAI croton o il 
in aceto ne Olt til e dorsal ;:lIld vcntra l sides of the cars of Itlicc, and ca r 
swe lling responses \vc rc ITl casured 24 and 4B h later. A II1l1 C~I S Lln! nl e llts were 
do ne with a Peacock engin cer's 11lic rOIlH!ter b y a blinded in vesti g:,to r. 
T reatment of M ice with Anti -IL-4 mAb Mice were inj ected intra ve-
nously (i. v.) with 5 rng of ami-I [.-4 neutralizi nl,; IlI Ab I I B I I (5 I11 g in 500 
J.L1 of PBS) I h bl!fo re chall en l,;l! with I % or 0 .5% TNCJ3. Control g ro ups 
we re injected i.v. w ith 5 m g of iso typc contro ll11Ab (5 .11g in 500 II I of l'13S) 
at th e S3 nlC tilll c . All cx pe ril11 c I1 ts were pc rfo rl11cd with fo ur or five 111icc pe r 
group. 
Statistical Analysis Sig llifi cant differe n ces be twcen g ro ups were eva lu-
ated \\l ith a l'..vo-tai led Stud cnt's t tcst. M ca n dilTcrc l1 cc~ w c rc cO llside red 
signifi can t when p < 0.05. 
Extraction of mRNA At vario ll s ti mes afcc r chall e llge with TNCJ3 o r 
vehicle , cars we re exc ised . Spli t cars were Roared denna l side down in 2.4 
ull its pcr m l dispase II (Uoehrillger Mannheim . India napo lis. IN) I'o r 20 ,"in 
at 37"C. the epidermis was scparated fro m the dm'mis, and all tissues were 
jmnl cdiatcly sto red ill liquid Il i tro~c ll . Subsequelltl y, fro zel1 t issues wen.: 
ground wi th m ortar and pestle w hile heing kept t"rozl!n with additional 
vo lUll1es of liqu id nitrogen. Frozc l1 tiss li e powder was the n h o tlloge ni zcd 
with Polyrron PTA 7 homogenizer (Kinem atica. Littau. Switze rland) ill lys is 
buffe r [1 00 111M Tris-H C I (pH ~l.U). 500 mM LiC I. 10 mM e th ylellediamin l! 
tctraacetic ac id, '1 % SDS. and 5 111M d ithiothreiro iJ :md ce lltrifugcd at 
2000 X .~ for 15 l11ill at ·loC. InRNA was ex tracred from supe l"lla tallts by 
using Dynabcads O ligo(dT) 2s (Dynal. Great N eck . NY) as desc ribed (En" 
and Katz, 1994) . T he cO ll centn.ti o n of iso lated .1IRNA was dete rlllined by 
its optica l de nsity at 260 .1111 using the \Varburg-Chri stian equatio ll 
(Beckman DU-60 Nucleic Acid Sort-Pac . I'u ll e rtoll , CAl . 
Reverse T ranscription- Coupled PCR (RT -PCR) and Liquid Hy-
bridization The R T reaction was performed hy using specific primillg 
'HId the GClleA mp RNA PC I"l k.it (Pe rkin- Elmer Cetus. Norwa lk . CT). 
J3rieR y. 9 II g ot" mRNA w as reverse- tr:lIl scribed with Moloney 'lIl.rinc 
IL' u kclllia virus reverse trallscriptasc an d spec ifi c.:)' p ril11 CrS fori L-I /3. I L-2 . 
I L-4·. I L- I 0, I L- 12 p·IO . IFN-y. or g lyce raldehyde-3-phosphal"e dehydroge-
nase (G3 I'DH) . cDNAs obta ined were nm plificd by the PCR with a 
Perki ll-Elme r Cetus DNA T herm al Cycler. T he c)'c1 illg conditio ll s w ere 
dellatur:uiOIl fOr I mill at 94 °C. annealing for 1.5 Illin at 55°C (I L- I (3. I L-4. 
IL-l 0. IL- 12 p~O , G3 PDH) , (,3 °C (IL-2) . o r li4 °C (IFN-y), and pol),n l!r-
izatiOIl fo r 2 mill at 72°C. Primers uSl!d for I L-l {3. I L-2. IL-~ . I L- I O. and 
IFN-y were purchas'd fro m C lo lll"ech (Pa lo Alto. CAl . Primers for IL-1 2 
al1d G3 PDH were design ed by llsing known scqucnces o h ta in ed frOlll 
GCIIUallk . N ucleotide seq uell ces for 5' and Y primers and PC R cycles useel 
fo r l! ach primer pair arc o utlincd in Table I. Primers, mR.NA cOllcclll"ra-
(-io ll s. and peR. cycles were tirnlted to es tabli sh sta l1d nrd CliTTes to dcmon-
strate linearity. w hich allowed qutllltir:nivc an alysis of sign a l srre n g th . 
Five m icro li tc rs of amp li tied PC R products were h vbridized to an excess 
of .l °P-elld_labell!d pro bes as described (Euk alld K;rz . 1992). All prohes 
were conlp lc I11 c ntary to inte rnal seq ucll ces o f the spec ili c PC R. produc ts. 
T he sequellces of the probes we re as fo llows: 
G3 PDH prohe. 5' -GAGTGGGAGTTGCTGTTGAAGTCGC: 
IL-I{3 J.lrobe. 5'-AGCTTTCAGCT ATATGGGTCCGACAGCAC: 
IL-2 probe, 5'-TCGAATTGGCACTCAAATGTGTTGT AGAG: 
IL-4 probe . 5 ' -AAAATATGCGAAGCACCTTGGAAGCCCTAC; 
IL- IO probe . 5'-GC TTGTAGACACCTTGGTCTTCCAGCTTA; 
IL- 12 p40 prohe. 5'-GCAGGTGTA TGGCCAGCATCTAGAAACT 
IFN-y probe. 5'-CTTGCTGTTGCTGAAGAAGGTAGTAATCAG. 
After hybridizati o ll. samples were c lectro J.llr o resed Oil 4'% po lyac rylamide 
!(cl s. dri ed . alld developed fo r 2-24 h (Kodak UIO-MAX films. R oches ter . 
NY). Autorad iograms were analyzed by usillg a dell sito m eo'ic oprica l 
sea llllcr (M icro rek 300FS . Torrall ce. CAl alld Ima!,:e 1.36 sofrware (Na-
tiollal Instin.tcs o f I-Iealrh , Uctlresda . M D). Sigllal stre ll !,:th of each c)'to kille 
was ""I"I1.alized hy usin g G3 P!)!-I signals. 
R .ESULTS 
Specific Enhancement of IFN-y and IL-4 mRNA Signal 
Strength in the Elicitation Phase of CS ml:tNA was ex-
tracted fi 'o lll cpid e rmis and demlis of ca rs of n :l'ivc un c h a ll e n ged 
mice, T N CB-sen sitized mi ce c hall e nged w ith TNCB (TIT grou p), 
o r veh icle (T / V g roup) , o r n;l'ive TNC13-cha ll cnged mice ( - IT 
gro u p) at various t imes a fter c hall e n ge. Nine nan ogral11s of mRNA 
were al11p li ~led b y R T -PCR lIsing prim e rs sp eciftc for thc indi ca ted 
cyroki ne mRN As (Fig 1). 
In untreated e pide rmis. mRN As e n cod in g IL- I /3. IL-2 . IL-I O, 
and I L-1 2 p-1-0 w e re presenr con stitutive ly, whereas no mRN A 
transcripts were detected wh c n primers fu r IL--1- and IF N - y were 
used (Fig lA). A fte r TNCB t rcatme n t , th e m ost striki n g findings 
were those o bse r ved whcn prim c rs for IFN-y and I L--1- were used. 
T h cre was marked e nhan cement of I I'N-y mR.NA sig nal s 2 -1· and 
72 h afte r c hall e llge in the TIT g ro up a s comparcd to the T I V and 
- IT g ro ups (Fig 1A). T h c re was also n striking e nhancem ent of 
IL--1- mRNA sig nal strc n gth 2 -1- h after c hall c n ge in th e TIT g roup 
408 ASADA ET ilL 
A 
IFN·Y 
IL·1 0 
'00 IL. ' ~ 
750 
500 
DH 
Sir 
0Ir 
Sir I 
, 
I 
I I [ 
I ; 
! 
, I 0 01492472 
..,(~-L.~--L....~ 
1 ........... 104 ......................... 1 
• BASELINE 
• ·rr 
o TN 
13 m 
Time after challenge (hr) 
..., 
T H E JOU R.NAL OF IN V ESTIGATIVE DERMATOLOGI.' 
8 'OOO"o:=IF:7N • .."Y,.---------, 'OOO"o-;;-IL-;·' T.11 - - - -----, 
.!!! 
'c 
:J 
.g 
7ii 
E 
B 
'iii 
c: 
{g 'OOI~:;;::~=======~ 
~ 75 g 
:c 50 
~ 25 
75 
50 
25 
.... -_ .... - ..... - .. ,.. .... _-
75 
o ..,(~~4~--...Z.....z.. 
'DO 
751r 
501r 
251r 
1 ~ -__ w_M~ ~w w_w~w_ 1 
.L .! 1) I-w-w----- . .. __ .. w~ 1 
G3PDH 
1m BASELINE 
• 
·rr 
0 TN 
lEI Trr 
Time after challenge (hr) 
Figure 1. Specific enhancement of IFN-')I and IL-4 mRNA signal strength in the epidermis (A) and dermis (B). mRNA was extracted frol11 
epidermis and dennis of cars of naive unchallenged mice (baseline). 3'% TN CI3-sensitized mice chall enged with 1 'X, TNCI3 (TIT) or vehicle (T I V) . or naive 
1'Xo T NCI3-challenged mice (- IT) at 1. 4, 9, 24, and 72 h afi:e r challenge. R T -PCR and Iiguid hybridization were performed. Signal strength was assessed 
by dens itometry. OaW arc representative of three experiments. 
as compared to the oth er groups. With each of the other cytokine 
mRN A signals, there was little change noted between the TIT and 
-IT groups. We attributed these changes to the nonspecific 
infl ammatory changes induced by 1 % T N CB. 
In th e dermi s, mliliAs encoding each of th e cytokin es were 
present constituti vely (Fig lB). After challenge, the findings in the 
dermis were very simil ar to those o bserved in the ep idermis. There 
was a marked enhancem e nt of mRNA sign als for IFN -)I (at 4, 9, 
24, and 72 h) and for rL-4 (at 9, 24, and 72 h) after challenge (Fig 
lB) . All of the othe r cytokin e mRNA changes observed after 
challenge did not depend stric tly on prior sensitization . 
Independent time course studies using two additional groups of 
m ice also showed the elicitation phase-specifi c upl'egul atio n ofIL-4 
mRNA expression both in the epidermis and in th e dermis (data not 
shown). 
Mast-Cell-Deficient WIW Mice Have Enhanced IL-4 
mRNA Expression Since elicitation-phase-specific upregula-
tion of IL-4 mRNA was observed in the epidermis and dermis, we 
dete rmin ed the cellul ar so urce ofIL-4 mliliA. As IL-4 is known to 
be produced by mast cells (Brown et Ill, 1987; Bradding et Ill , 1992) 
and Th2 cells, we exa mined IL-4 mR.NA in mast-cell-deficient 
IV /Jljl" mice (Kitam ura et ai, 1978) after chall enge with TNCB. 
As shown in Figure 2A, IIVIHI" mi ce in TIT group showed the 
sa me degree of CS response as co n tro l + I + mice in the TIT gro up . 
Furthermo re, IL- 4 mR.NA in the dermi s of IV/HI" mice in the TIT 
gro up clea rl y in creased in comparison with the - IT and T IV 
gro ups, and the signa l strength was almost the same as + I + mi ce 
in the TIT g ro up (Fig 2B). 
Cytokine Expression Patterns Are Altered by Anti-IL-4 
mAb Treatment To examin e the e ffect of e ndogenous lL-4 on 
cytokine expressio n patterns in skin , cytokine mRNA in the skin of 
mice treated w ith anti-TL-4 mAb was meas ured 24 h after chal-
lenge . Significant increases in I FN-')I, rL-2, IL-12 p40 , and IL-1,l3 
mRNA, and slight increases in IL- 4 mRN A w ere observed in the 
dermis of anti-IL-4 mAb treated mi ce, compared to that in control 
mice injected with isotype contro l mAb (Fig 3) . In contrast, 
anti-IL-4 mAb treatment had no signifi can t effect on IL-l 0 mRNA 
expressio n (Fig 3) or on cytokine mliliA pattern s in the epidermis 
(data not shown). 
Enhancement of the CS Response by Anti-IL-4 Treatment 
To inves tiga te the role of endogenous IL- 4 in the e licitation phase 
of CS, neutra lizing anti -IL-4 mAb was administered to mice. Mice 
were painted o n abdominal skin with TNCB twice to enhan ce the 
car swelling response and were injected i. v. with anti-IL- 4 mAb 1 h 
before challenge. For chall enge, we used 0.5'y., TNCB instead of1 % 
TNCB to I'edu ce irritant responses . Figure 4A shows that anti-lL-4 
Il1Ab treatm ent significan tly in creased the ear sw ellin g 24 h after 
challenge , compared to mice injected with isotype control mAb 
(p < 0.05 , n = 3 experim en ts; p > 0.05, II = 1 experiment) . T hese 
resul ts suggest that treatm ent with anti-rL-4 mAb enhances CS by 
neutralizing the effect of IL-4 produced endogenously after chal-
lenge with TNCB . 
W e also examined the effects of anti-IL-4 mAb treatment on dle 
irrita.nt (ll onimll1uno logica lly m ediated) response induced by cro-
ton oil. In contrast to the CS response, anti-IL-4 mAb administra-
tion had no e ffect on the irri tant responses (Fig 4B) . 
DIS C USSION 
Epidermi s, which contains keratinocytes, Lange rhans cells , and 
epidermal T cells, is a rich so urce of cytokines (Sauder e/ ai, 1984: 
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Figure 2. Mast-cell-deficient mice ( WIW mice) show the same ear 
swelling response and the same cnhanccd IL-4 mRNA signal 
strength as normal control mice (+1+ mice). Mice sensitized with 3'1. 
T NCB were challenged with I 'X, TNCI3 on day G. and car swelling (A) and 
IL-4 mRNA express ion in the dermis (8) were assessed 24 h after challenge. 
- 1- , Naive unchallenged mice; - IT. ",five '1 % T NCI3-challengcd mice; 
T / V . 3% TNCI3-sensiti zed and vehicle challcnged; T I T. 3'% TNCB-
sensitized and 1% TNCB-challenged mice. E"."rIJnrs. SD. 
Luger and Schwarz, 1990; Enk and Katz. 1992). Dermis is also an 
inlportant source of cytokines. because various cells infiltrate the 
dennis during inflamm atory and immune reactions in skin. CS is 
g enerall y conside red a T h1-type ullmune response. Although the 
cytokine network changes during the sensitization phase of CS 
have been studied (Enk and Katz. 1992) , similar ti m e- course studies 
of the e licitati o n phase of CS ha ve not been previously reported . 
Therefore, we examined th e expression of cytokine mRNA de-
riv ed from epiderm al cells and inflammatory cells both in epide rmis 
and de rmis during this response. 
Our data uldicate that ch allenge with h apten capable of trigger-
mg the elicitation phase of CS ca uses selective profound ch'll1ges in 
mRNA express ion of IFN - )' and IL-4 in both th e epidermis and the 
dennis. Altho ugh m any other changes were o bserved Ul the 
d ynamics of cytokin e mRNA appearance in the epidermis and 
dermis, we believe tha t virtuall y all of these changes were not 
specific to the e licitation phase of CS, because similar changes were ' 
noted in the - IT con tro l group . T his latter point is consisten t with 
the studies of Kondo e( al (1994b), w ho altho ugh n ot studyin g 
IFN- )" IL-2, IL-4, o r .IL-12 cytokine ml~A expressio n , described 
that n onspecifi c (irritant) reac tions showed less upregulation of 
REGULATION O F CONTACT SENSITIVITY BY IL-4 409 
TIT -I-
.e Mean ratio 
s::::: .e« s::::: 
0 « E 0 of E~ ,-
- - signal strength u u Q) Q) I Q) ,- a.::! 
'-s::::: >- ,.!. s::::: ( Anti-IL-4 mAb ) 
--0 o c: 0 Isotype mAb Z ~« z 
IFN-y 2.50 :t. 0.42 
IL-2 3.33 :t. 0.76 
IL-4 1.27 :t. 0.24 
IL-10 0.88 :t. 0.09 
IL-12 p40 4.51 :t. 1.10 
IL-1~ 2.19 :t. 0.34 
G3PDH 
Figure 3. Cytokinc expression patterns are altered by anti-IL-4 
mAb trcatll1cnt. Mice sensitized with 3% TNCB were injected i.v. with 
5 mg ofanti- lL-4 mAb or an isotype controll11Ab 1 h before challenge with 
1 % TNCI3 on day 6. Cytokine mRNA expression in the dermis was assessed 
with RT-PCR 24 h after challenge. -1- , NaIve unchallenged mice; TIT, 
TNCB-s"nsitiz"d and challenged mice. Data of autoradiography are repre-
sentative of three experiments. Karios of signal strength for each experiment 
were calculated as fo llows: signal strength of anti-IL-4 mAb divided by 
signal strength of isotype mAb. Data arc mean :!: SO (11 = 3). 
epiderma By del;ved fL-1j3 , IL-6, and IL- 10 cytokine mRNAs than 
do allergic contact sensitivity reactions. 
It is notable that IL-4 was signi ficantly induced in the dennis and 
the epidermis afte r T N CB ch allen ge ofTN CB-sensitized mice, but 
not in skin from naive TNCB-challenged mice. These findings are 
in concert w ith those of O hm en e( al (1995) w h o demonstrated that 
in allergic contact dermatitis in human beulgs, IL-4 mRNA was 
m ost strongly expressed . IL-4 is a well-known cytokin e product of 
T h 2 cells (Mosmann e( ai, 1986); however, recent studies h ave 
indicated tll at lL-4 can also be produced by connective tissue mast 
cell s (Bradding ct ai, 1992), which are found in large numbers in 
skin (Mikhail and Miller-Milinska, 1964). Therefore, to b etter 
delineate the cellul ar source of IL-4 mRNA, we examined IL-4 
mRNA expression in mast-cell-deficient mice (W'/ vV' mice) . The 
expression ofIL- 4 mRNA in the dermis of VI/ I T¥" mice, as well as 
in control n ormal mice, was induced during the e licitation phase of 
CS. T his result indicates that the IL-4 mRNA induced during the 
e licitation phase is probably n ot derived from mast cells. T herefore, 
the IL-4 ml~A expressed durulg the elicitation phase of CS is 
410 ASADA /'iT A t THE j OU I~AL OF INVESTIGATIVE DERMATOLOGY 
A B 
15 15 Exp.2 
* 
N 
___ Antl·IL-4 mAb 6 30 25~---------------------, 
;;- 10 10 
0 
',( 
E 
.§. 
II) 
II) 
.. 
c 
..: 
u 
£ 
~ 15 15 Exp. 4 ., 
.. 
.E 
~ Exp. 1 
-o-Isotype mAb )( E 
~No injection .§. 25 
-4--rr II) II) 20 
.. 
* P<O.05 c 
.>< 
0 15 
;S 
~ 
., 10 Q) 
.5 
.. 
II) 
., -o-Isotypo mAb 
Exp. 2 
20 
15 
10 
.. 10 10 
II) 
., 
~ 
Q) 
t; 
E 24 48 24 48 
u 
E Time atter challenge (hr) 
24 48 
Time after challenge (hr) 
Fig ure 4 . Anti-IL-4 mAb treatment significantly enhanc es CS, but not irrita nt, responses. (A) Mice sensitized with 3%, TNCB were painted again 
o n the abdom inal skin wi th I 'X. T N C13 o n da y 4 and chall enged w ith 0.5% TNC O on day 6. O ne ho ur be fo re challenge. mice were injected i.v. w ith 5 mg 
ofan ti-I L-4 mAb o r iso type co ntro lm Ab. and ca r swelling w as l11e il slI red 24 il nd 48 h ilfte r chall enge. Data arc fro m fo m indepe ndent experimc nts. (13) Mice 
were inj ected i.v. w ith 5 I11 g of an ti- IL- 4 m Ab or isotypc contro l mAb 1 h befo re painting the Cil rs wi th 1% croto n o il. Datil arc from two independent 
cXp Cr i I11l! I"ltS. Error ba,.s, SO . 
pro babl y deri ved fi'om T h2 cells, altho ug h o ur data do no t mle o ut 
the possibili ty of IL- 4 produ ctio n by other cell types such as C D4-
T ce lls (Seder c( ai , 1992; Z lotni k e( ai, 1992; Erard cl ai, 1993) or 
basophils (Sede r eI ai , 199 1; Aoki e( ai , 1995). 
Previo us studies have show n tha t IL-4 modula tes the productio n 
of several cytokines by T lymph ocytes (Pe leman e( ai, 1989; Vercelli 
c( al. 1990; Po w rie l'1 ai, 1993) and by m acrophages (Essner el ai , 
1989; Ha rt e ( ai, 1989) . T herefore, we blocked endogeno us I L-4 
and examin ed the e ffects o n cyto kine expression pattern s at th e site 
of inflamm ation . T rea tm en t o f mice w ith anti-IL-4 m Ab signifi-
cantl y in creased mRNA expressio n o f IL- lt3, IL-2, IFN-),. and 
IL-12 , cytokill es importa n t fo r T hl resp o nses. Tn additi o n , anti-TL-4 
mAb treatm ent s.ignifican tly enhanced the m agnitllde of ear sw e ll-
ing, s ugges ~ing that endogeno us IL-4 was indeed importa nt in the 
do w rtregulatio n of CS. T his suppression o f CS by endogeno us IL-4 
m ay be m ediated at least in part by inhibi tion o f synth esis of 
cytokines th at media te T h 1 responses . 
Other studies exa mining th e e ffects of IL-4 on the elicita ti o n 
ph ase of CS have demonstrated dispara te res ul ts (Gautam el ai, 
1992; B erg c ( ai, 1995 ; Salerno c ( ai, 199 5). I In co n tl'ast to o ur 
fi ndings, Sa lern o c ( al (1995), using an ti-I L-4 m Ab and an tisense 
o li gonucleotides to lL-4 ill lI il' O, dcm onstratcd th at IL-4 is an 
essen tial cytokine in CS reactions. T hey al so showed that injection 
of an ti- IL-4 m Ab had no o bservable c ffects on an tigen-dri ven 
productio n of T hl cytokin es by lymph node ce lls. D ifferences 
between th eir results and o urs might be due to differences in strains 
of m ice, the dose of anti-IL-4 m Ab, o r cytokine assay sys tem s. 
Furthermore , Berg el al (1995) show ed that CS reactions in IL-4 
gene-ta rgeted mi ce d id not di ffer !Tom those in wild-type mice and 
co ncluded that IL-4 docs not regula te CS reactions. Al tho ugh the 
reasolls fo r the di screpancy between their mu tan t mice study and 
o ur rL-4 blocking stud y is no t cl ear, di fferences m ay be explain ed 
by overprod uctio n of other immunosuppresive cytokines such as 
IL- l 0 , IL-13, and TGF- t3 in mu ta nt mi ce that wou ld co mpensate 
for a lack in IL-4. O n the othe r hand , Gautam e ( al (1 992) showed 
that IL-4 suppressed the eli citati on phase of CS. T hey inj ected IL-4 
and anti-IL-4 m Ab ill lI illo . T heir resul ts . as well as those o f Mai cl 
ai , I wh o sho wed th at I L-4- tre;lted mi ce had strongly diminished ca r 
swellin g (CS) respo nses, are consisten t w ith o ur da ta. 
X u e( al (1 996) have recentl y p roposed tha t in con tact sensitiza-
tio n there is the inductio n of two po pul atio ns o f T ceUs that, 
thro ugh the ir cytokin e pro fil es, ha ve opposin g functions. T hey also 
I M ai A. Ogil vie A. Oicde rtnann T . Sandcr C . Lev inc A. Plewig G . 
Rockcn M: ) Jll ilest D enllato/1 06: 8 13. 1996 (abstr) . 
pro vide data that, in draining lymph node ce lls. after CS induction 
there arc IFN- ),-produ cin g effector C D8 -1• T cc ll s and lL-4/ LL-l 0-
producing C D4 + T cell s that do wnregulate the respo nse. T hese 
findin gs probably re late to those presented herein in that we found 
enhan ced expression o f TFN-)' and IL-4 cyto kin e mRNAs in the 
skin du ring the elicitation phase o f C S. T hus, modul ation of 
potcntially harmful T hl type reactions that arc o bserved ill au to-
immuni ty and in o ther im m uno logicall y m edi ated diseases (as in 
thi s study, in contact sensitivi ty) by IL-4, a T h2 respo nse cytokine, 
m ay provide a nove l approach to the trea tm ent of these diseases. 
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